Metformin transiently inhibits colorectal cancer cell proliferation as a result of either AMPK activation or increased ROS production
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Metformin transiently inhibits colorectal cancer cell proliferation as a result of either AMPK activation or increased ROS production ; volume:7 ; number:1 ; day:22 ; month:11 ; year:2017 ; pages:1-12 ; date:12.2017
Scientific reports ; 7, Heft 1 (22.11.2017), 1-12, 12.2017
- Keyword
-
Krebs
Onkologie
- Creator
-
Mogavero, Angela
- Contributor
-
Maiorana, Maria Valeria
Zanutto, Susanna
Varinelli, Luca
Bozzi, Fabio
Belfiore, Antonino
Volpi, Chiara C.
Gloghini, Annunziata
Pierotti, Marco A.
Gariboldi, Manuela
SpringerLink (Online service)
- DOI
-
10.1038/s41598-017-16149-z
- URN
-
urn:nbn:de:1111-20180409840
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:55 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mogavero, Angela
- Maiorana, Maria Valeria
- Zanutto, Susanna
- Varinelli, Luca
- Bozzi, Fabio
- Belfiore, Antonino
- Volpi, Chiara C.
- Gloghini, Annunziata
- Pierotti, Marco A.
- Gariboldi, Manuela
- SpringerLink (Online service)
Other Objects (12)
Metformin attenuates silica-induced pulmonary fibrosis via AMPK signaling
Rosiglitazone metformin adduct inhibits hepatocellular carcinoma proliferation via activation of AMPK/p21 pathway
Low-dose metformin and PEN2-dependent lysosomal AMPK activation: benefits outnumber side effects
Low-dose metformin and PEN2-dependent lysosomal AMPK activation: benefits outnumber side effects
Metformin exerts anti-AR-negative prostate cancer activity via AMPK/autophagy signaling pathway
Metformin alleviates neurocognitive impairment in aging via activation of AMPK/BDNF/PI3K pathway
ROS signaling under metabolic stress: cross-talk between AMPK and AKT pathway
Either, Rupert
Either, Rupert
Anxiolytic effect of antidiabetic metformin is mediated by AMPK activation in mPFC inhibitory neurons
Metformin attenuates lung ischemia-reperfusion injury and necroptosis through AMPK pathway in type 2 diabetic recipient rats
Telomere stabilization by metformin mitigates the progression of atherosclerosis via the AMPK-dependent p-PGC-1α pathway
Metformin attenuates silica-induced pulmonary fibrosis via AMPK signaling
Rosiglitazone metformin adduct inhibits hepatocellular carcinoma proliferation via activation of AMPK/p21 pathway
Low-dose metformin and PEN2-dependent lysosomal AMPK activation: benefits outnumber side effects
Low-dose metformin and PEN2-dependent lysosomal AMPK activation: benefits outnumber side effects
Metformin exerts anti-AR-negative prostate cancer activity via AMPK/autophagy signaling pathway
Metformin alleviates neurocognitive impairment in aging via activation of AMPK/BDNF/PI3K pathway
ROS signaling under metabolic stress: cross-talk between AMPK and AKT pathway
Either, Rupert
Either, Rupert
Anxiolytic effect of antidiabetic metformin is mediated by AMPK activation in mPFC inhibitory neurons
Metformin attenuates lung ischemia-reperfusion injury and necroptosis through AMPK pathway in type 2 diabetic recipient rats
Telomere stabilization by metformin mitigates the progression of atherosclerosis via the AMPK-dependent p-PGC-1α pathway
Metformin attenuates silica-induced pulmonary fibrosis via AMPK signaling
Rosiglitazone metformin adduct inhibits hepatocellular carcinoma proliferation via activation of AMPK/p21 pathway
Low-dose metformin and PEN2-dependent lysosomal AMPK activation: benefits outnumber side effects
Low-dose metformin and PEN2-dependent lysosomal AMPK activation: benefits outnumber side effects
Metformin exerts anti-AR-negative prostate cancer activity via AMPK/autophagy signaling pathway
Metformin alleviates neurocognitive impairment in aging via activation of AMPK/BDNF/PI3K pathway
ROS signaling under metabolic stress: cross-talk between AMPK and AKT pathway
Either, Rupert
Either, Rupert
Anxiolytic effect of antidiabetic metformin is mediated by AMPK activation in mPFC inhibitory neurons
Metformin attenuates lung ischemia-reperfusion injury and necroptosis through AMPK pathway in type 2 diabetic recipient rats